Last 12 months
Inside the activity.
0 purchase rows · 25 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 8 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 20, 2019 Filed Aug 22, 2019 18:01 UTC |
HEGDE SHARATHCHANDRA SSVP, Research
|
Tax withholdingOrdinary Shares | 2,272 | $21.51 | $48,870.72 |
DisclosureSEC source: 0001179110-19-009788 · edgar.xml · nonDerivative · entry 1 HEGDE SHARATHCHANDRA S · CIK 0001668696 · SVP, Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,900 Read SEC document |
| August 20, 2019 Filed Aug 22, 2019 18:08 UTC |
WORBOYS PHILIP DSVP, Translational Science
|
Tax withholdingOrdinary Shares | 2,272 | $21.51 | $48,870.72 |
DisclosureSEC source: 0001179110-19-009800 · edgar.xml · nonDerivative · entry 1 WORBOYS PHILIP D · CIK 0001668718 · SVP, Translational Science 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,127 Read SEC document |
| August 20, 2019 Filed Aug 22, 2019 18:03 UTC |
PITZER KENNETH RSVP, Prod Strat & Comm Plng
|
Tax withholdingOrdinary Shares | 2,272 | $21.51 | $48,870.72 |
DisclosureSEC source: 0001179110-19-009792 · edgar.xml · nonDerivative · entry 1 PITZER KENNETH R · CIK 0001668775 · SVP, Prod Strat & Comm Plng 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,106 Read SEC document |
| August 20, 2019 Filed Aug 22, 2019 18:06 UTC |
Shafer Bradford JEVP, Gen. Counsel, Secretary
|
Tax withholdingOrdinary Shares | 3,084 | $21.51 | $66,336.84 |
DisclosureSEC source: 0001179110-19-009796 · edgar.xml · nonDerivative · entry 1 Shafer Bradford J · CIK 0001302448 · EVP, Gen. Counsel, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,901 Read SEC document |
| August 20, 2019 Filed Aug 22, 2019 22:07 UTC |
Winningham Rick EDirector · Chief Executive Officer
|
Tax withholdingOrdinary Shares | 8,678 | $21.51 | $186,663.78 |
DisclosureSEC source: 0001179110-19-009798 · edgar.xml · nonDerivative · entry 1 Winningham Rick E · CIK 0001302443 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,083,133 Read SEC document |
| August 20, 2019 Filed Aug 22, 2019 22:05 UTC |
SABESAN VIJAYSVP, Technical Operations
|
Tax withholdingOrdinary Shares | 1,472 | $21.51 | $31,662.72 |
DisclosureSEC source: 0001179110-19-009794 · edgar.xml · nonDerivative · entry 1 SABESAN VIJAY · CIK 0001767807 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,753 Read SEC document |
| August 20, 2019 Filed Aug 22, 2019 22:02 UTC |
PASQUALONE FRANKSVP, Chief Comm Ops Officer
|
Tax withholdingOrdinary Shares | 2,335 | $21.51 | $50,225.85 |
DisclosureSEC source: 0001179110-19-009790 · edgar.xml · nonDerivative · entry 1 PASQUALONE FRANK · CIK 0001597334 · SVP, Chief Comm Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,759 Read SEC document |
| August 20, 2019 Filed Aug 22, 2019 22:00 UTC |
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc
|
Tax withholdingOrdinary Shares | 2,710 | $21.51 | $58,292.10 |
DisclosureSEC source: 0001179110-19-009785 · edgar.xml · nonDerivative · entry 1 HAUMANN BRETT K · CIK 0001607733 · SVP Clin Dev & Chief Med Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,968 Read SEC document |
| August 20, 2019 Filed Aug 22, 2019 21:58 UTC |
BRADY ANNPresident, TBIL
|
Tax withholdingOrdinary Shares | 1,073 | $21.51 | $23,080.23 |
DisclosureSEC source: 0001179110-19-009783 · edgar.xml · nonDerivative · entry 1 BRADY ANN · CIK 0001767974 · President, TBIL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,184 Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 22:05 UTC |
Hindman Andrew A.SVP, Chief Financial Officer
|
GrantShare Option (Right to Buy) · Derivative | 260,000 | $0.00 Strike: $16.94 | $0.00 |
DisclosureSEC source: 0001179110-19-008497 · edgar.xml · derivative · entry 2 Hindman Andrew A. · CIK 0001607965 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,000 Underlying: Ordinary Shares · 260,000 shares Expires 2029-06-30 F1 · derivative.exercise_date: This option may be exercised with respect to the first 25% of the shares subject to this option when optionee completes 12 months of continuous service after the Grant Date. This option may be exercised with respect to an additional 1/48th of the shares subject to this option when optionee completes each month of continuous service thereafter. The option shall be fully vested and exercisable on the 4-year anniversary of the Grant Date provided optionee has remained in continuous service through such date. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 22:05 UTC |
Hindman Andrew A.SVP, Chief Financial Officer
|
GrantOrdinary Shares | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-008497 · edgar.xml · nonDerivative · entry 1 Hindman Andrew A. · CIK 0001607965 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Read SEC document |
| May 20, 2019 Filed May 22, 2019 18:19 UTC |
WORBOYS PHILIP DSVP, Translational Science
|
Tax withholdingOrdinary Shares | 2,272 | $19.84 | $45,076.48 |
DisclosureSEC source: 0001179110-19-006541 · edgar.xml · nonDerivative · entry 1 WORBOYS PHILIP D · CIK 0001668718 · SVP, Translational Science 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,399 F1 · balance_after: Includes 1,027 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2019. Read SEC document |
| May 20, 2019 Filed May 22, 2019 18:07 UTC |
HEGDE SHARATHCHANDRA SSVP, Research
|
Tax withholdingOrdinary Shares | 2,272 | $19.84 | $45,076.48 |
DisclosureSEC source: 0001179110-19-006522 · edgar.xml · nonDerivative · entry 1 HEGDE SHARATHCHANDRA S · CIK 0001668696 · SVP, Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,172 Read SEC document |
| May 20, 2019 Filed May 22, 2019 18:11 UTC |
PITZER KENNETH RSVP, Prod Strat & Comm Plng
|
Tax withholdingOrdinary Shares | 2,272 | $19.84 | $45,076.48 |
DisclosureSEC source: 0001179110-19-006527 · edgar.xml · nonDerivative · entry 1 PITZER KENNETH R · CIK 0001668775 · SVP, Prod Strat & Comm Plng 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,378 Read SEC document |
| May 20, 2019 Filed May 22, 2019 18:15 UTC |
Shafer Bradford JEVP, Gen. Counsel, Secretary
|
Tax withholdingOrdinary Shares | 2,488 | $19.84 | $49,361.92 |
DisclosureSEC source: 0001179110-19-006534 · edgar.xml · nonDerivative · entry 1 Shafer Bradford J · CIK 0001302448 · EVP, Gen. Counsel, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,985 F1 · balance_after: Includes 1,027 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2019. Read SEC document |
| May 20, 2019 Filed May 22, 2019 22:17 UTC |
Winningham Rick EDirector · Chief Executive Officer
|
Tax withholdingOrdinary Shares | 8,678 | $19.84 | $172,171.52 |
DisclosureSEC source: 0001179110-19-006538 · edgar.xml · nonDerivative · entry 1 Winningham Rick E · CIK 0001302443 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,091,811 F1 · balance_after: Includes 1,027 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2019. Read SEC document |
| May 20, 2019 Filed May 22, 2019 22:03 UTC |
BRADY ANNPresident, TBIL
|
Tax withholdingOrdinary Shares | 1,073 | $19.84 | $21,288.32 |
DisclosureSEC source: 0001179110-19-006516 · edgar.xml · nonDerivative · entry 1 BRADY ANN · CIK 0001767974 · President, TBIL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,257 Read SEC document |
| May 20, 2019 Filed May 22, 2019 22:13 UTC |
SABESAN VIJAYSVP, Technical Operations
|
Tax withholdingOrdinary Shares | 1,474 | $19.84 | $29,244.16 |
DisclosureSEC source: 0001179110-19-006530 · edgar.xml · nonDerivative · entry 1 SABESAN VIJAY · CIK 0001767807 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,225 F1 · balance_after: Includes 1,027 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2019. Read SEC document |
| May 20, 2019 Filed May 22, 2019 22:05 UTC |
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc
|
Tax withholdingOrdinary Shares | 2,705 | $19.84 | $53,667.20 |
DisclosureSEC source: 0001179110-19-006520 · edgar.xml · nonDerivative · entry 1 HAUMANN BRETT K · CIK 0001607733 · SVP Clin Dev & Chief Med Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,678 Read SEC document |
| May 20, 2019 Filed May 22, 2019 22:09 UTC |
PASQUALONE FRANKSVP, Chief Comm Ops Officer
|
Tax withholdingOrdinary Shares | 1,604 | $19.84 | $31,823.36 |
DisclosureSEC source: 0001179110-19-006524 · edgar.xml · nonDerivative · entry 1 PASQUALONE FRANK · CIK 0001597334 · SVP, Chief Comm Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 323,094 F1 · balance_after: Includes 1,027 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2019. Read SEC document |
| May 17, 2019 Filed May 20, 2019 22:02 UTC |
O'Connor DonalDirector
|
SaleOrdinary Shares | 2,673 | $20.19 | $53,967.60 |
DisclosureSEC source: 0001179110-19-006410 · edgar.xml · nonDerivative · entry 2 O'Connor Donal · CIK 0001625377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,571 F1 · price: This transaction was executed in multiple trades at prices from $20.181000 to $20.2274. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 16, 2019 Filed May 20, 2019 22:02 UTC |
O'Connor DonalDirector
|
SaleOrdinary Shares | 1,327 | $21.00 | $27,867.00 |
DisclosureSEC source: 0001179110-19-006410 · edgar.xml · nonDerivative · entry 1 O'Connor Donal · CIK 0001625377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,244 Read SEC document |
| April 30, 2019 Filed May 2, 2019 22:17 UTC |
Gunderson Robert V JRDirector
|
GrantShare Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $23.85 | $0.00 |
DisclosureSEC source: 0001179110-19-005455 · edgar.xml · derivative · entry 3 Gunderson Robert V JR · CIK 0001302450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Ordinary Shares · 6,000 shares Expires 2029-04-29 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| April 30, 2019 Filed May 2, 2019 22:17 UTC |
Gunderson Robert V JRDirector
|
GrantOrdinary Shares | 8,385 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-005455 · edgar.xml · nonDerivative · entry 1 Gunderson Robert V JR · CIK 0001302450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,630 Read SEC document |
| April 30, 2019 Filed May 2, 2019 18:34 UTC |
WHITESIDES GEORGE MDirector
|
GrantShare Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $23.85 | $0.00 |
DisclosureSEC source: 0001179110-19-005469 · edgar.xml · derivative · entry 4 WHITESIDES GEORGE M · CIK 0001233438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Ordinary Shares · 6,000 shares Expires 2029-04-29 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| April 30, 2019 Filed May 2, 2019 18:34 UTC |
WHITESIDES GEORGE MDirector
|
GrantOrdinary Shares | 8,385 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-005469 · edgar.xml · nonDerivative · entry 1 WHITESIDES GEORGE M · CIK 0001233438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,963 Read SEC document |
| April 30, 2019 Filed May 2, 2019 18:21 UTC |
MALKIEL BURTON GDirector
|
GrantShare Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $23.85 | $0.00 |
DisclosureSEC source: 0001179110-19-005457 · edgar.xml · derivative · entry 3 MALKIEL BURTON G · CIK 0001184677 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Ordinary Shares · 6,000 shares Expires 2029-04-29 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| April 30, 2019 Filed May 2, 2019 18:21 UTC |
MALKIEL BURTON GDirector
|
GrantOrdinary Shares | 8,385 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-005457 · edgar.xml · nonDerivative · entry 1 MALKIEL BURTON G · CIK 0001184677 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,142 Read SEC document |
| April 30, 2019 Filed May 2, 2019 22:23 UTC |
MITCHELL DEAN JDirector
|
GrantShare Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $23.85 | $0.00 |
DisclosureSEC source: 0001179110-19-005461 · edgar.xml · derivative · entry 2 MITCHELL DEAN J · CIK 0001199297 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Ordinary Shares · 6,000 shares Expires 2029-04-29 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| April 30, 2019 Filed May 2, 2019 22:23 UTC |
MITCHELL DEAN JDirector
|
GrantOrdinary Shares | 8,385 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-005461 · edgar.xml · nonDerivative · entry 1 MITCHELL DEAN J · CIK 0001199297 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,571 Read SEC document |
| April 30, 2019 Filed May 2, 2019 18:32 UTC |
RINGROSE PETER SDirector
|
GrantShare Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $23.85 | $0.00 |
DisclosureSEC source: 0001179110-19-005467 · edgar.xml · derivative · entry 2 RINGROSE PETER S · CIK 0001199298 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Ordinary Shares · 6,000 shares Expires 2029-04-29 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| April 30, 2019 Filed May 2, 2019 18:32 UTC |
RINGROSE PETER SDirector
|
GrantOrdinary Shares | 8,385 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-005467 · edgar.xml · nonDerivative · entry 1 RINGROSE PETER S · CIK 0001199298 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,999 Read SEC document |
| April 30, 2019 Filed May 2, 2019 22:36 UTC |
YOUNG WILLIAM DDirector
|
GrantShare Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $23.85 | $0.00 |
DisclosureSEC source: 0001179110-19-005472 · edgar.xml · derivative · entry 2 YOUNG WILLIAM D · CIK 0001217420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Ordinary Shares · 6,000 shares Expires 2029-04-29 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| April 30, 2019 Filed May 2, 2019 22:36 UTC |
YOUNG WILLIAM DDirector
|
GrantOrdinary Shares | 8,385 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-005472 · edgar.xml · nonDerivative · entry 1 YOUNG WILLIAM D · CIK 0001217420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,695 Read SEC document |
| April 30, 2019 Filed May 2, 2019 22:14 UTC |
BROSHY ERANDirector
|
GrantShare Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $23.85 | $0.00 |
DisclosureSEC source: 0001179110-19-005453 · edgar.xml · derivative · entry 2 BROSHY ERAN · CIK 0001256230 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Ordinary Shares · 6,000 shares Expires 2029-04-29 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| April 30, 2019 Filed May 2, 2019 22:14 UTC |
BROSHY ERANDirector
|
GrantOrdinary Shares | 8,385 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-005453 · edgar.xml · nonDerivative · entry 1 BROSHY ERAN · CIK 0001256230 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,571 Read SEC document |
| April 30, 2019 Filed May 2, 2019 22:44 UTC |
Molineaux SusanDirector
|
GrantShare Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $23.85 | $0.00 |
DisclosureSEC source: 0001179110-19-005477 · edgar.xml · derivative · entry 3 Molineaux Susan · CIK 0001553389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Ordinary Shares · 6,000 shares Expires 2029-04-29 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| April 30, 2019 Filed May 2, 2019 22:44 UTC |
Molineaux SusanDirector
|
GrantOrdinary Shares | 8,385 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-005477 · edgar.xml · nonDerivative · entry 1 Molineaux Susan · CIK 0001553389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,385 Read SEC document |
| April 30, 2019 Filed May 2, 2019 22:28 UTC |
O'Connor DonalDirector
|
GrantShare Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $23.85 | $0.00 |
DisclosureSEC source: 0001179110-19-005465 · edgar.xml · derivative · entry 2 O'Connor Donal · CIK 0001625377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Ordinary Shares · 6,000 shares Expires 2029-04-29 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| April 30, 2019 Filed May 2, 2019 22:28 UTC |
O'Connor DonalDirector
|
GrantOrdinary Shares | 8,385 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-005465 · edgar.xml · nonDerivative · entry 1 O'Connor Donal · CIK 0001625377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,571 Read SEC document |
| April 30, 2019 Filed May 2, 2019 22:11 UTC |
Smaldone Alsup LaurieDirector
|
GrantShare Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $23.85 | $0.00 |
DisclosureSEC source: 0001179110-19-005451 · edgar.xml · derivative · entry 2 Smaldone Alsup Laurie · CIK 0001589602 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Ordinary Shares · 6,000 shares Expires 2029-04-29 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| April 30, 2019 Filed May 2, 2019 22:11 UTC |
Smaldone Alsup LaurieDirector
|
GrantOrdinary Shares | 8,385 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-005451 · edgar.xml · nonDerivative · entry 1 Smaldone Alsup Laurie · CIK 0001589602 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,347 Read SEC document |
| March 05, 2019 Filed Mar 6, 2019 19:20 UTC |
HEGDE SHARATHCHANDRA SSVP, Research
|
SaleOrdinary Shares | 5,690 | $24.50 | $139,405.00 |
DisclosureSEC source: 0001179110-19-003477 · edgar.xml · nonDerivative · entry 2 HEGDE SHARATHCHANDRA S · CIK 0001668696 · SVP, Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,444 F2 · price: This transaction was executed in multiple trades at prices from $24.4953 to $24.515. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 19:20 UTC |
HEGDE SHARATHCHANDRA SSVP, Research
|
SaleOrdinary Shares | 3,343 | $25.06 | $83,763.55 |
DisclosureSEC source: 0001179110-19-003477 · edgar.xml · nonDerivative · entry 1 HEGDE SHARATHCHANDRA S · CIK 0001668696 · SVP, Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,134 F1 · price: This transaction was executed in multiple trades at prices from $25.00 to $25.27. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 18:15 UTC |
HEGDE SHARATHCHANDRA SSVP, Research
|
Tax withholdingOrdinary Shares | 3,770 | $27.00 | $101,790.00 |
DisclosureSEC source: 0001179110-19-002413 · edgar.xml · nonDerivative · entry 1 HEGDE SHARATHCHANDRA S · CIK 0001668696 · SVP, Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,477 Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 18:27 UTC |
WORBOYS PHILIP DSVP, Translational Science
|
Tax withholdingOrdinary Shares | 3,986 | $27.00 | $107,622.00 |
DisclosureSEC source: 0001179110-19-002435 · edgar.xml · nonDerivative · entry 1 WORBOYS PHILIP D · CIK 0001668718 · SVP, Translational Science 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,644 Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 18:18 UTC |
PITZER KENNETH RSVP, Prod Strat & Comm Plng
|
Tax withholdingOrdinary Shares | 3,674 | $27.00 | $99,198.00 |
DisclosureSEC source: 0001179110-19-002424 · edgar.xml · nonDerivative · entry 1 PITZER KENNETH R · CIK 0001668775 · SVP, Prod Strat & Comm Plng 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,650 Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 18:22 UTC |
Shafer Bradford JEVP, Gen. Counsel, Secretary
|
Tax withholdingOrdinary Shares | 5,798 | $27.00 | $156,546.00 |
DisclosureSEC source: 0001179110-19-002429 · edgar.xml · nonDerivative · entry 1 Shafer Bradford J · CIK 0001302448 · EVP, Gen. Counsel, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,446 Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 23:25 UTC |
Winningham Rick EDirector · Chief Executive Officer
|
Tax withholdingOrdinary Shares | 13,477 | $27.00 | $363,879.00 |
DisclosureSEC source: 0001179110-19-002433 · edgar.xml · nonDerivative · entry 1 Winningham Rick E · CIK 0001302443 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,099,462 Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 23:23 UTC |
SULIMAN SHEHNAAZSVP, Corp Dev & Strategy
|
Tax withholdingOrdinary Shares | 5,763 | $27.00 | $155,601.00 |
DisclosureSEC source: 0001179110-19-002431 · edgar.xml · nonDerivative · entry 1 SULIMAN SHEHNAAZ · CIK 0001713070 · SVP, Corp Dev & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,198 F1 · balance_after: Includes 1,731 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.